"The
Report Pharmaceutical Deal Trends (2010-2015) and In-Depth Analysis
of Recent Deal Activity provides information on pricing, market
analysis, shares, forecast, and company profiles for key industry
participants. - MarketResearchReports.biz"
GBI
Research’s latest report, ""Pharmaceutical Deal Trends
(2010–2015) and In-Depth Analysis of Recent Deal Activity""
discusses deal-making trends for a range of deal types, such as
Mergers & Acquisitions (M&A) and strategic alliances. It also
examines preference by deal type, along with disclosed deal values
from 2010 to July 2015, covering start-ups, mid-level players, and
big players.
Pharmaceutical
companies use deal activity to enhance their research activities,
regulatory approach, geographic presence, commercialization, and
sales. The increasing development of biologics, especially in
oncology, has given a significant boost to activity in recent years.
Analysis suggests that while the number of deals in 2015 (until July)
was lower than the number of deals in 2014, deal value in 2015 has
already exceeded that of 2014. Looking at the entire period, although
strategic deals were more numerous, M&A deals had the highest
deal value. Partnerships were the most preferred type of deal
activity, but saw the lowest deal value. North America led in terms
of region, followed by Europe and Asia-Pacific. Key deals covered in
this report include the acquisition of Allergen by Actavis, asset
transactions between Novartis and GlaxoSmithKline, and the
partnership between Pfizer and Merck.
View Report At
http://www.marketresearchreports.biz/analysis/399070
Scope
- Which challenges in the pharmaceutical industry are encouraging deal activity?
- How important is deal activity to the market?
Overview of deal activity from
2010 to 2015 -
- What are the trends for M&A and strategic deals, and what are the key differences between the sectors?
- What was the trend for regional involvement in each year?
- How do variations in terms of therapy area preference affect deal activity?
Detailed analysis of recent
deal activity -
- How do announced and completed deals vary?
- How do deals in 2014 and 2015 compare in terms of quarterly volume and value?
- Which regions or therapy areas have encouraged recent deal activity?
- Who are the key players?
Complete analysis of recent M&A
deals -
- How do M&A deal types differ in terms of number and value?
- Which regions and therapy areas have been involved in M&A deals since 2013?
- Who are the most important players in M&A deals?
- What was the rationale behind key M&A deals?
Complete analysis of recent
strategic alliances -
- What are the different strategic alliance deal types?
- Which key regions and therapy areas have been involved in strategic alliances since 2013?
- Which important molecule types and routes of administration have recently been involved in strategic alliances?
- Who are the key players in strategic alliance deals?
- What was the rationale behind key strategic alliance deals?
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/399070
Reasons to buy
This report will allow you to -
- Gain an insight into pharmaceutical deal activity via in-depth analysis of the current pharmaceutical industry, along with a focus on the most lucrative regions and therapy areas for both M&A and strategic deals
- Examine detailed analysis of key players, covering companies involved in M&A and strategic alliance deals, important deal activity for all deal types, and deals involving companies with the most numerous and highest-value deals.
- Understand how the current deals market is changing, using analysis of deals by molecule type, route of administration, and stage of development.
- Determine the most appropriate deal activity for overcoming challenges and enhancing performance, including detailed analysis of the rationale behind key recent deals.
Table
of Contents
Executive
summary
Introduction
Overview
Traditional
Model vs. Evolving Model
Factors
Promoting Deal Activity
One-Stop
Solution to Current Pharmaceutical Challenges
Deal
Types
Overview
of Pharmaceutical Deals from 2010 to 2015
Number
of Pharmaceutical Deals and Value by Year
Pharmaceutical
Deals by Region
Pharmaceutical
Deals by Therapy Area
Overall
Deal Analysis for 2014 and 2015
Announced
and Completed Deals
Number
of Deals and Deal Value by Deal Type
Number
of Deals and Deal Value by Quarter
Regions
of Deal Occurrence
Therapy
Areas Promoting Deal Activity
Key
Players in Deal Activity by Number of Deals and Deal Value
Mergers
and Acquisitions Deal Activity for 2014 and 2015
Mergers
and Acquisitions by Type of Deal and Deal Value
Mergers
and Acquisitions by Region
Mergers
and Acquisitions by Therapy area
Key
Players in Mergers and Acquisitions
Description
of Key Deals by Value
Strategic
Alliances Deal Activity for 2014 and 2015
Strategic
Alliance Deals by Type of Deal and Deal Value
Strategic
Alliance Deals by Aggregate Deal Value, Upfront Payment and Milestone
Payment
Strategic
Alliance Deals by Region
Strategic
Alliance Deals by Therapy Area
Strategic
Alliance Deals by Product Phase
Strategic
Alliance Deals by Molecule Type
Strategic
Alliance Deals by Route of Administration
Key
Players in Strategic Alliances
Description
of Key Deals by Value
Bibliography
and Appendix
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment